MD 1984, UCLouvain
Assistant Professor of Medicine 95, Harvard Medical School
Agrégation de l’Enseignement Supérieur 97, UC Louvain
Full Professor of Medicine and Pharmacology 04, UC Louvain
J-L Balligand developed the core of his research projects in the biochemistry and cellular biology of nitric oxide synthases (NOS) including their regulation in cardiovascular tissues. He initiated the research on the role of NOS in cardiomyocyte contractility which is being extended in the context of myocardial remodelling and regeneration, e.g. in response to catecholamines and beta-adrenoceptors. His group also provided seminal observations on the mechanism of endothelial dysfunction by LDL-cholesterol and pleiotropic effects of hypolipemiant drugs (e.g. statins) on the endothelium. He currently is Head of the Pole of Pharmacology and Therapeutics and President of the Institut de Recherche Expérimentale et Clinique (IREC), Faculty of Medicine, UC Louvain. He also is practicing Physician at the Cliniques Universitaires Saint-Luc and teaches cardiovascular physiology and pharmacology at the Faculty of Medicine. He is member of the Royal Academy of Medicine of Belgium and Board member of the Health competitiveness cluster of the Wallonia Region, BioWin.